Holen Sie sich die Stockscreener-App
3.10
12.80%
-0.455
Schlusskurs vom Vortag:
$3.555
Offen:
$3.46
24-Stunden-Volumen:
14,267
Relative Volume:
1.34
Marktkapitalisierung:
$4.61M
Einnahmen:
$27.40M
Nettoeinkommen (Verlust:
$-17.12M
KGV:
-0.029
EPS:
-106.8896
Netto-Cashflow:
$-24.99M
1W Leistung:
-22.31%
1M Leistung:
-1.90%
6M Leistung:
-1.27%
1J Leistung:
-74.97%
1-Tages-Spanne:
$3.02
$3.48
1-Wochen-Bereich:
$3.02
$4.05
52-Wochen-Spanne:
$2.5211
$16.97
Dna X Inc Stock (SONM) Company Profile
Firmenname
Dna X Inc
Sektor
Branche
Telefon
650-378-8100
Adresse
4445 EASTGATE MALL, SAN DIEGO, TX
Compare SONM vs MS, GS, SCHW, HOOD, IBKR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
3.10 | 4.61M | 27.40M | -17.12M | -24.99M | -106.89 |
MS
Morgan Stanley
|
186.64 | 293.13B | 128.77B | 20.37B | 39.02B | 12.37 |
GS
Goldman Sachs Group Inc
|
891.91 | 259.70B | 128.57B | 20.97B | 112.72B | 64.79 |
SCHW
Charles Schwab Corp
|
95.94 | 165.91B | 28.33B | 9.42B | 9.76B | 5.0426 |
HOOD
Robinhood Markets Inc
|
110.52 | 99.37B | 4.65B | 1.89B | -2.09B | 2.0676 |
IBKR
Interactive Brokers Group Inc
|
87.49 | 39.64B | 10.76B | 4.56B | 35.82B | 2.326 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-10-31 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-07-18 | Eingeleitet | B. Riley FBR | Buy |
| 2019-07-09 | Hochstufung | National Securities | Neutral → Buy |
| 2019-06-10 | Eingeleitet | National Securities | Neutral |
| 2019-06-04 | Eingeleitet | Lake Street | Buy |
| 2019-06-04 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Dna X Inc Aktie (SONM) Neueste Nachrichten
A planned share sale leaves Ginkgo Bioworks (DNA) CFO holding 49,448 shares directly. - Stock Titan
Applied DNA Sciences, Inc. (OTC: BNBX) Share Price, BNBX Stock News, BNBX Share Price & Updates - Kalkine
AIxCrypto Holdings, Inc. (AIXC) stock price, news, quote and history - Yahoo Finance UK
Scribe Therapeutics Inc. Common Stock (NASDAQ: SCTX) Stock Price, News & Analysis - kalkine.ca
VEON Ltd. (VEON) stock price, news, quote and history - uk.finance.yahoo.com
VEON Ltd. (VEON) Stock Price, News, Quote & History - Yahoo! Finance Canada
VEON Ltd. (VEON) stock price, news, quote and history - Yahoo Finance Singapore
Ginkgo Bioworks (NYSE: DNA) director sells 5,000 shares near $7.08 - Stock Titan
Director plans potential 5,000-share sale at Ginkgo Bioworks (NYSE: DNA) - Stock Titan
Ginkgo Bioworks Holdings (NYSE:DNA) Stock Forecast & Analyst Predictions - Simply Wall Street
Press Release Service: Researchers Gain Faster Access to Complex DNA as Integrated DNA Technologies and Ansa Biotechnologies Expand Ordering Platform - CRISPR Medicine News
Sonim Technologies Maintains Nasdaq Compliance Amid Monitoring Period - The Globe and Mail
DNA regained Nasdaq equity compliance but faces one-year mandatory monitor - TradingView
SONM Q3 2024 Earnings: Loss Narrower Than Expected, Shares Rise 5.8%Profit Recovery Report - vinanet.vn
SONM Q3 2024 Earnings: Loss Narrower Than Expected, Shares Rise 5.8%Management Guidance Update - careplusvn.com
Sonim Technologies Adopts Cash-Based Director Compensation Structure - The Globe and Mail
DNA awards Substitute Cash Grants to board including CEO Mike Mulica - TradingView
DNA X (SONM) turns to cash after equity plan runs out of shares - Stock Titan
Ginkgo Bioworks (DNA) CFO logs 743 RSU vesting, tax sale - Stock Titan
DNA X, Inc. Reports Second Quarter 2026 Financial Results - The Manila Times
DNA X Q2 EPS improves to $(0.91) from $(14.15) YoY - scanx.trade
DNA X, Inc. 2Q 2026: Revenue $0 EPS $(0.92) — 10-Q Summary - TradingView
SONM: Net income surged to $5.1M as the company pivoted to crypto trading and raised $5M in new capital - TradingView
DNA X (Nasdaq: SONM) profits from phone sale while crypto platform is in the red - Stock Titan
DNA X: Q2 Earnings Snapshot - marketscreener.com
DNA X: Q2 Earnings Snapshot - AOL.com
DNA X: Q2 Earnings Snapshot - KTVB
DNA X, Inc. Reports Second Quarter 2026 Financial Results - The Manila Times
C&F Financial Corporation Announces Quarterly Dividend - The Manila Times
Beam Global Reports Second Quarter 2026 Operating Results - The Manila Times
VVC Exploration Corporation Files Annual Financial Statements - The Manila Times
DNA X raised $5 million after its quarter ended, while its trading platform had no revenue - Stock Titan
DNA (SONM) Quarter in Focus: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Market Reaction: The Stock Ends Down 0.60% in Latest TradingGuidance Update - vinanet.vn
DNA X Inc: Expects Revenue From Trading Platf - Moomoo
DNA X, Inc. Reports Second Quarter 2026 Financial Results - Yahoo Finance
12 Information Technology Stocks Moving In Monday's After-Market Session - Benzinga
Aon plc (AON) Holds Near $355.83 as Insurance Broker Consolidates Between Support and ResistanceHigh Volume Node - vinanet.vn
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Just Slashed This Year's Revenue Estimates By 22% - simplywall.st
Sonim Technologies delays quarterly filing amid consolidation - TipRanks
DNA X, Inc. (SONM) delays Q2 2026 filing but projects smaller net loss - Stock Titan
SONM Q2'26 Earnings: EPS estimate is 5.22 USD - TradingView
META_TITLE_QUOTE - Yahoo Finance
DNA X, Inc. (SONM) raises $2.5M and targets Nasdaq equity rule compliance - Stock Titan
DNA X, Inc. (SONM) investor Lytton discloses 6.8% stake in latest 13G/A - Stock Titan
DNA X Inc. (SONM) Holds Flat at $3.56 as Range-Bound Trading PersistsChannel Breakout - vinanet.vn
DNA X Inc. (SONM) Holds Flat at $3.56 as Range-Bound Trading PersistsVolume Breakout Ideas - dars.gov.et
Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination - Yahoo Finance
Star Wars Zero Company is a very safe XCOM descendant, but its most interesting parts are found in its Midnight Suns DNA - PC Gamer
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Slammed 36% But Getting In Cheap Might Be Difficult Regardless - 富途牛牛
SONM Q3 2024 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesPost-Announcement Reaction - vinanet.vn
Finanzdaten der Dna X Inc-Aktie (SONM)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.29%
16.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):